BioStock: BioInvent strengthens the organisation with COO
Swedish biotech BioInvent strengthened its pipeline of cancer treatments in 2021, entering the new year with four candidates in clinical phase, which is soon to be expanded with a fifth. Given the higher pace and increased regulatory work this entails, the company has now strengthened the organisation with Marie Moores as Chief Operating Officer. Moores told BioStock about why she chose to take on this challenge, and how she will contribute to BioInvent’s current positive momentum.Read the full interview with Marie Moores at biostock.se: https://www.biostock.se/en/2022/02/bioinvent-